Back to search

Article

New exploration of the treatment of nontuberculous mycobacterium lung disease: Moxifloxacin may be a first-line drug for the treatment of NTM-PD

2022-02-23

Abstract excerpt

<h4>Objective: </h4> By comparing the results of moxifloxacin sensitivity test and clinical efficacy in nontuberculous mycobacterium lung disease (NTM-PD) further confirm the necessity of moxifloxacin as a first-line drug for the treatment of nontuberculous mycobacterium（NTM）. <h4>Method: </h4> Positive samples of sputum, bronchoscope brush or alveolar lavage fluid cultured in Bactec MGIT960 system were retrospect...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bda57a2f-f364-51ba-a5a0-daffcfcfeaf6
DOI
10.21203/rs.3.rs-1272399/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
New exploration of the treatment of nontuberculous mycobacterium lung disease: Moxifloxacin may be a first-line drug for the treatment of NTM-PDDOI 10.21203/rs.3.rs-1272399/v1
Incorporating direct molecular diagnostics in management algorithms for nontuberculous mycobacteria: Is it high time?Semantic proximity
Understanding nontuberculous mycobacterial lung disease: it’s been a long time comingSemantic proximity
Analysis of non-tuberculous mycobacteria types in high tuberculosis endemic areasSemantic proximity
High Sensitivity of Targeted Next-Generation Sequencing on Patients with Suspected Mycobacteria Infectious Diseases: A Prospective Matched Cohort StudySemantic proximity
Analysis of the types and characteristics of non-tuberculous mycobacteria in high endemic areas of tuberculosisSemantic proximity
Nanopore-targeted sequencing: A new and effective technique for the diagnosis of non-tuberculous mycobacteria pulmonary diseaseSemantic proximity
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.Semantic proximity
Clinical Characteristics, Susceptibility Profiles, and Treatment of Rapidly Growing Mycobacteria in a Tertiary General Hospital in ChinaSemantic proximity
Application Value of BALF mNGS for Screening Patients With Mycobacterium Tuberculosis Infection in General HospitalsSemantic proximity
Clinical presentation and treatment outcomes of extrapulmonary nontuberculous mycobacterial infections with rapid and slow growth rates in Cali, ColombiaSemantic proximity
Clinical characteristics of non-tuberculous mycobacterium in central China were analyzed based on the macropathogenic mNGS sequencing technologySemantic proximity
Epidemiology of Nontuberculous Mycobacteria in Nanjing and MAB_0540 Mutations Associated with Clofazimine Resistance in Mycobacterium abscessusSemantic proximity
Select a neighboring publication to make it the new centre.